"","gene","GO.Slim.Term","adj.pval.treatment","scaffold","start","end","uniprot.id","uniprot_taxa.id","Uniprot.Name","GO.IDs","GO.Descript"
"1","PGEN_.00g005660","cytoskeletal activity",0.00193871303220277,"Scaffold_01",14272638,14385002,"Q91ZU6","DYST_MOUSE","Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)","GO:0001725; GO:0003779; GO:0005509; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005882; GO:0005925; GO:0005938; GO:0007155; GO:0007409; GO:0008017; GO:0008090; GO:0009898; GO:0014069; GO:0014704; GO:0015629; GO:0015630; GO:0016020; GO:0016021; GO:0030018; GO:0030056; GO:0030424; GO:0031110; GO:0031122; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042383; GO:0042803; GO:0045104; GO:0046907; GO:0048471; GO:0051010; GO:0060053; GO:0097038; GO:1904115","actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; neurofilament cytoskeleton [GO:0060053]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; regulation of microtubule polymerization or depolymerization [GO:0031110]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060]"
"2","PGEN_.00g013900","cytoskeletal activity",7.01528658880582e-08,"Scaffold_01",35824608,35872288,"Q80TN7","NAV3_MOUSE","Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1)","GO:0005524; GO:0005634; GO:0005635; GO:0005640; GO:0007026; GO:0007399; GO:0008017; GO:0022008; GO:0030336; GO:0031116; GO:0032703; GO:1905929","nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; negative regulation of cell migration [GO:0030336]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; positive regulation of invadopodium disassembly [GO:1905929]; positive regulation of microtubule polymerization [GO:0031116]"
"3","PGEN_.00g014630","cytoskeletal activity",0.034160026851891,"Scaffold_01",38059667,38113107,"Q6ZPV2","INO80_MOUSE","Chromatin-remodeling ATPase INO80 (EC 3.6.4.-) (DNA helicase-related INO80 complex homolog 1) (DNA helicase-related protein INO80)","GO:0000070; GO:0000724; GO:0003677; GO:0003779; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005874; GO:0005886; GO:0006281; GO:0006302; GO:0006338; GO:0006351; GO:0008094; GO:0010571; GO:0016604; GO:0016887; GO:0030307; GO:0031011; GO:0034644; GO:0042393; GO:0042766; GO:0043014; GO:0043044; GO:0043618; GO:0045944; GO:0051225; GO:0051301; GO:0070914; GO:0071479; GO:2000045","cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; nucleosome mobilization [GO:0042766]; positive regulation of cell growth [GO:0030307]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; transcription, DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914]"
"4","PGEN_.00g017860","cytoskeletal activity",0.0320715779321826,"Scaffold_01",48136795,48272553,"Q9C0G6","DYH6_HUMAN","Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)","GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959","cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
"5","PGEN_.00g028280","cytoskeletal activity",0.0432844767781971,"Scaffold_01",78164630,78265700,"Q9JHU4","DYHC1_MOUSE","Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)","GO:0000278; GO:0002177; GO:0003341; GO:0005524; GO:0005623; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007018; GO:0007097; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0072382; GO:0090235; GO:0120162; GO:1904115; GO:1905832","axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell [GO:0005623]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; filopodium [GO:0030175]; manchette [GO:0002177]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; cytoplasmic mRNA processing body assembly [GO:0033962]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; nuclear migration [GO:0007097]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]"
"6","PGEN_.00g043360","cytoskeletal activity",0.00026872587429312,"Scaffold_02",28694545,28729634,"A1ZA47","ZASP_DROME","PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein)","GO:0001725; GO:0001952; GO:0003779; GO:0005913; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061","actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; cell-cell adherens junction [GO:0005913]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]"
"7","PGEN_.00g049510","cytoskeletal activity",0.00046221698864548,"Scaffold_02",45350315,45373894,"Q8TDM6","DLG5_HUMAN","Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG)","GO:0001837; GO:0005737; GO:0005886; GO:0005913; GO:0007165; GO:0008013; GO:0008092; GO:0008285; GO:0014069; GO:0030011; GO:0030054; GO:0030159; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0035556; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045880; GO:0051965; GO:0060441; GO:0060999; GO:0065003; GO:0071896; GO:0072205; GO:0098609","cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; receptor signaling complex adaptor activity [GO:0030159]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186]"
"8","PGEN_.00g050270","cytoskeletal activity",0.0131993181259566,"Scaffold_02",47462804,47517164,"P59759","MRTFB_MOUSE","Myocardin-related transcription factor B (MRTF-B) (MKL/myocardin-like protein 2)","GO:0001701; GO:0001764; GO:0001889; GO:0003007; GO:0003700; GO:0003713; GO:0003779; GO:0005634; GO:0005737; GO:0007507; GO:0007517; GO:0010467; GO:0010468; GO:0030036; GO:0030900; GO:0031175; GO:0045844; GO:0045893; GO:0045944; GO:0048514; GO:0048568; GO:0048738; GO:0051145","cytoplasm [GO:0005737]; nucleus [GO:0005634]; actin binding [GO:0003779]; DNA-binding transcription factor activity [GO:0003700]; transcription coactivator activity [GO:0003713]; actin cytoskeleton organization [GO:0030036]; blood vessel morphogenesis [GO:0048514]; cardiac muscle tissue development [GO:0048738]; embryonic organ development [GO:0048568]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; muscle organ development [GO:0007517]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; smooth muscle cell differentiation [GO:0051145]"
"9","PGEN_.00g057650","cytoskeletal activity",0.000376623787655412,"Scaffold_02",68547910,68600615,"Q28205","TBCD_BOVIN","Tubulin-specific chaperone D (Beta-tubulin cofactor D) (Tubulin-folding cofactor D)","GO:0000226; GO:0000278; GO:0005096; GO:0005813; GO:0005829; GO:0005912; GO:0005923; GO:0006457; GO:0007021; GO:0007023; GO:0010812; GO:0016328; GO:0031115; GO:0034333; GO:0048487; GO:0048667; GO:0070830","adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; beta-tubulin binding [GO:0048487]; GTPase activator activity [GO:0005096]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]"
"10","PGEN_.00g066340","cytoskeletal activity",0.000112044076940847,"Scaffold_03",23576108,23642329,"A2ASS6","TITIN_MOUSE","Titin (EC 2.7.11.1) (Connectin)","GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0071688; GO:1901897","A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]"
"11","PGEN_.00g081000","cytoskeletal activity",5.71559959478455e-05,"Scaffold_04",6562308,6600640,"Q27802","DYHC2_TRIGR","Cytoplasmic dynein 2 heavy chain 1 (Dynein heavy chain isotype 1B)","GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005886; GO:0005929; GO:0007018; GO:0007275; GO:0030030; GO:0030286","cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; multicellular organism development [GO:0007275]"
"12","PGEN_.00g102230","cytoskeletal activity",0.0237400607993744,"Scaffold_04",61170576,61178433,"Q9R1K9","CETN2_MOUSE","Centrin-2 (Caltractin isoform 1)","GO:0000278; GO:0005509; GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0006289; GO:0007099; GO:0007283; GO:0008017; GO:0015031; GO:0031683; GO:0032391; GO:0032465; GO:0032795; GO:0036064; GO:0044615; GO:0051028; GO:0051301; GO:0070390; GO:0071942","centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390]; XPC complex [GO:0071942]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017]; cell division [GO:0051301]; centriole replication [GO:0007099]; mitotic cell cycle [GO:0000278]; mRNA transport [GO:0051028]; nucleotide-excision repair [GO:0006289]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283]"
"13","PGEN_.00g110260","cytoskeletal activity",4.43673910783518e-05,"Scaffold_05",15669855,15764255,"Q39565","DYHB_CHLRE","Dynein beta chain, flagellar outer arm","GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514","cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]"
"14","PGEN_.00g131030","cytoskeletal activity",0.0241944468378098,"Scaffold_06",5295042,5305191,"Q9NXW9","ALKB4_HUMAN","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4 (Alkylated DNA repair protein alkB homolog 4) (DNA N6-methyl adenine demethylase ALKBH4) (EC 1.14.11.51) (Lysine-specific demethylase ALKBH4) (EC 1.14.11.-)","GO:0003779; GO:0005730; GO:0005737; GO:0006325; GO:0006482; GO:0016491; GO:0016706; GO:0030496; GO:0031032; GO:0032451; GO:0035516; GO:0036090; GO:0046872; GO:0070938; GO:0070989; GO:0080111; GO:1902275","contractile ring [GO:0070938]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleolus [GO:0005730]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; actin binding [GO:0003779]; demethylase activity [GO:0032451]; metal ion binding [GO:0046872]; oxidative DNA demethylase activity [GO:0035516]; oxidoreductase activity [GO:0016491]; actomyosin structure organization [GO:0031032]; chromatin organization [GO:0006325]; cleavage furrow ingression [GO:0036090]; DNA demethylation [GO:0080111]; oxidative demethylation [GO:0070989]; protein demethylation [GO:0006482]; regulation of chromatin organization [GO:1902275]"
"15","PGEN_.00g151360","cytoskeletal activity",0.0301793441062283,"Scaffold_06",57783330,57868391,"Q9JMH9","MY18A_MOUSE","Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210)","GO:0000139; GO:0005524; GO:0005793; GO:0005802; GO:0005856; GO:0005903; GO:0007030; GO:0016459; GO:0016477; GO:0030054; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0045202; GO:0045335; GO:0048194; GO:0050714; GO:0051015; GO:0071346; GO:0090161; GO:0090164; GO:1903028","actomyosin [GO:0042641]; brush border [GO:0005903]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]"
"16","PGEN_.00g153140","cytoskeletal activity",0.0214094479527275,"Scaffold_07",1037155,1079880,"Q12955","ANK3_HUMAN","Ankyrin-3 (ANK-3) (Ankyrin-G)","GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007016; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259","axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]"
"17","PGEN_.00g159920","cytoskeletal activity",0.000608858996323151,"Scaffold_07",20096094,20100380,"P24587","AKAP5_RAT","A-kinase anchor protein 5 (AKAP-5) (A-kinase anchor protein 150 kDa) (AKAP 150) (P150) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein)","GO:0001664; GO:0001934; GO:0003779; GO:0005516; GO:0005623; GO:0005737; GO:0005856; GO:0005886; GO:0006605; GO:0007193; GO:0007194; GO:0008179; GO:0009898; GO:0010524; GO:0010738; GO:0014069; GO:0014850; GO:0016323; GO:0017124; GO:0019900; GO:0019901; GO:0019904; GO:0021510; GO:0021766; GO:0030346; GO:0030425; GO:0031527; GO:0031698; GO:0032279; GO:0032590; GO:0032591; GO:0032991; GO:0034237; GO:0035254; GO:0036394; GO:0042307; GO:0043025; GO:0043197; GO:0043198; GO:0043267; GO:0043271; GO:0043624; GO:0044877; GO:0045121; GO:0045296; GO:0045762; GO:0048471; GO:0050775; GO:0050811; GO:0051602; GO:0060076; GO:0060090; GO:0060135; GO:0070886; GO:0071417; GO:0097110; GO:0098978; GO:0099092; GO:0099149; GO:1903078","asymmetric synapse [GO:0032279]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; excitatory synapse [GO:0060076]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; G protein-coupled receptor binding [GO:0001664]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; amylase secretion [GO:0036394]; cellular protein complex disassembly [GO:0043624]; cellular response to organonitrogen compound [GO:0071417]; hippocampus development [GO:0021766]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of ion transport [GO:0043271]; negative regulation of potassium ion transport [GO:0043267]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein targeting [GO:0006605]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein kinase A signaling [GO:0010738]; response to electrical stimulus [GO:0051602]; response to muscle activity [GO:0014850]; spinal cord development [GO:0021510]"
"18","PGEN_.00g164740","cytoskeletal activity",0.0185970418706249,"Scaffold_07",32879160,32939450,"Q86VH2","KIF27_HUMAN","Kinesin-like protein KIF27","GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0021591; GO:0060271","cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591]"
"19","PGEN_.00g171340","cytoskeletal activity",0.0301793441062283,"Scaffold_08",8392053,8447234,"O43312","MTSS1_HUMAN","Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein)","GO:0001726; GO:0003785; GO:0005102; GO:0005737; GO:0007009; GO:0007155; GO:0007169; GO:0015629; GO:0030035; GO:0030036; GO:0030139; GO:0042802; GO:0050680; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:2001013","actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"
"20","PGEN_.00g171350","cytoskeletal activity",0.0120620312575807,"Scaffold_08",8447286,8475295,"Q8R1S4","MTSS1_MOUSE","Protein MTSS 1 (Metastasis suppressor protein 1) (Missing in metastasis protein)","GO:0001701; GO:0003779; GO:0003785; GO:0005102; GO:0005737; GO:0005912; GO:0007009; GO:0007015; GO:0007399; GO:0007517; GO:0010960; GO:0015629; GO:0030041; GO:0030282; GO:0032233; GO:0034334; GO:0042802; GO:0050680; GO:0051015; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:0072170; GO:2001013","actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; adherens junction maintenance [GO:0034334]; bone mineralization [GO:0030282]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; in utero embryonic development [GO:0001701]; magnesium ion homeostasis [GO:0010960]; metanephric tubule development [GO:0072170]; muscle organ development [GO:0007517]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; plasma membrane organization [GO:0007009]; positive regulation of actin filament bundle assembly [GO:0032233]; renal tubule morphogenesis [GO:0061333]"
"21","PGEN_.00g199570","cytoskeletal activity",0.00355968184063304,"Scaffold_09",24920274,24925015,"Q9VVI3","NEDD4_DROME","E3 ubiquitin-protein ligase Nedd-4 (DNedd4) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NEDD4)","GO:0000209; GO:0002092; GO:0004842; GO:0005112; GO:0005737; GO:0005886; GO:0006511; GO:0007219; GO:0007411; GO:0007528; GO:0008586; GO:0016199; GO:0016567; GO:0017022; GO:0019904; GO:0031623; GO:0043161; GO:0045732; GO:0045746; GO:0045807; GO:0045879; GO:0048814; GO:0051965; GO:0061630; GO:1905062; GO:1905306; GO:2000650","cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; myosin binding [GO:0017022]; Notch binding [GO:0005112]; protein domain specific binding [GO:0019904]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neuromuscular junction development [GO:0007528]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac myofibril assembly [GO:1905306]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synapse assembly [GO:0051965]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; ubiquitin-dependent protein catabolic process [GO:0006511]"
"22","PGEN_.00g206810","cytoskeletal activity",4.5224399725376e-05,"Scaffold_10",7584310,7700085,"Q8BW94","DYH3_MOUSE","Dynein heavy chain 3, axonemal (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3)","GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045505; GO:0051959","dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]"
"23","PGEN_.00g226840","cytoskeletal activity",0.0145479681407003,"Scaffold_11",7272683,7370846,"Q9VEN1","FLNA_DROME","Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)","GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051495","actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"
"24","PGEN_.00g227520","cytoskeletal activity",0.0382379150397033,"Scaffold_11",9517456,9568849,"Q17LW0","MYO7A_AEDAE","Myosin-VIIa (Protein crinkled)","GO:0003774; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0030898; GO:0032027; GO:0035317; GO:0048800; GO:0051015","cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]"
"25","PGEN_.00g233580","cytoskeletal activity",0.0404096067229422,"Scaffold_11",27099534,27108460,"P68372","TBB4B_MOUSE","Tubulin beta-4B chain (Tubulin beta-2C chain)","GO:0000226; GO:0000278; GO:0003725; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0043209; GO:0045298","cytoplasm [GO:0005737]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; tubulin complex [GO:0045298]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]"
"26","PGEN_.00g233770","cytoskeletal activity",0.000794258264075605,"Scaffold_11",27658467,27661179,"P11833","TBB_PARLI","Tubulin beta chain (Beta-tubulin)","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017","cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]"
"27","PGEN_.00g270640","cytoskeletal activity",0.0220809249535981,"Scaffold_13",30124160,30148040,"Q2KID4","DNAL1_BOVIN","Dynein light chain 1, axonemal","GO:0003774; GO:0005737; GO:0005874; GO:0030286; GO:0036158; GO:0042995; GO:0043014; GO:0045504","cell projection [GO:0042995]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; outer dynein arm assembly [GO:0036158]"
"28","PGEN_.00g274530","cytoskeletal activity",0.000782221588868464,"Scaffold_13",40767020,40771439,"P06603","TBA1_DROME","Tubulin alpha-1 chain","GO:0000226; GO:0000235; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007017; GO:0032418; GO:0048471","astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]"
"29","PGEN_.00g277430","cytoskeletal activity",2.00165589730783e-08,"Scaffold_14",3442934,3496237,"Q7Z7A1","CNTRL_HUMAN","Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110)","GO:0000086; GO:0005813; GO:0005815; GO:0005829; GO:0008092; GO:0010389; GO:0016020; GO:0051301; GO:0051493; GO:0090543; GO:0097711; GO:0120103","centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; cytoskeletal protein binding [GO:0008092]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of cytoskeleton organization [GO:0051493]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]"
"30","PGEN_.00g278620","cytoskeletal activity",0.00345255415974166,"Scaffold_14",6014261,6046448,"Q8K389","CK5P2_MOUSE","CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48)","GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0001578; GO:0005516; GO:0005623; GO:0005737; GO:0005794; GO:0005813; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0008274; GO:0015631; GO:0019901; GO:0022008; GO:0030054; GO:0031023; GO:0031116; GO:0035371; GO:0043015; GO:0044212; GO:0044877; GO:0045665; GO:0045893; GO:0046600; GO:0048471; GO:0090266; GO:0097431","cell [GO:0005623]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; gamma-tubulin ring complex [GO:0008274]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription regulatory region DNA binding [GO:0044212]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]"
"31","PGEN_.00g284620","cytoskeletal activity",0.019648332519261,"Scaffold_14",20735108,20737187,"Q9C0G6","DYH6_HUMAN","Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)","GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959","cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
"32","PGEN_.00g289090","cytoskeletal activity",2.79663988445674e-05,"Scaffold_14",29650979,29662232,"E9Q5G3","KIF23_MOUSE","Kinesin-like protein KIF23","GO:0000281; GO:0000915; GO:0003777; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0045171; GO:0051256; GO:0072383; GO:0072686; GO:0090543; GO:0097149","cell [GO:0005623]; centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; actomyosin contractile ring assembly [GO:0000915]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]"
"33","PGEN_.00g290400","cytoskeletal activity",0.0413023675513884,"Scaffold_14",32684479,32694765,"Q9C0G6","DYH6_HUMAN","Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)","GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959","cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
"34","PGEN_.00g290440","cytoskeletal activity",2.38813059478079e-05,"Scaffold_14",32730787,32752148,"Q91V41","RAB14_MOUSE","Ras-related protein Rab-14","GO:0000139; GO:0003924; GO:0005525; GO:0005764; GO:0005769; GO:0005770; GO:0005791; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006895; GO:0007589; GO:0008543; GO:0016324; GO:0019003; GO:0030133; GO:0030140; GO:0030659; GO:0031489; GO:0031901; GO:0032456; GO:0032482; GO:0032880; GO:0042175; GO:0042742; GO:0043231; GO:0045176; GO:0045335; GO:0045995; GO:0048471; GO:0055037; GO:0090387; GO:0097208; GO:0098993","alveolar lamellar body [GO:0097208]; anchored component of synaptic vesicle membrane [GO:0098993]; apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; apical protein localization [GO:0045176]; body fluid secretion [GO:0007589]; defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; phagolysosome assembly involved in apoptotic cell clearance [GO:0090387]; Rab protein signal transduction [GO:0032482]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880]"
"35","PGEN_.00g301440","cytoskeletal activity",0.00430436072419834,"Scaffold_15",10886361,10928410,"Q5T5Y3","CAMP1_HUMAN","Calmodulin-regulated spectrin-associated protein 1","GO:0000226; GO:0005516; GO:0005737; GO:0005874; GO:0007010; GO:0007026; GO:0008017; GO:0022604; GO:0030507; GO:0031113; GO:0031122; GO:0031175; GO:0051011","cytoplasm [GO:0005737]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113]"
"36","PGEN_.00g306890","cytoskeletal activity",0.0161087084801812,"Scaffold_15",24511937,24569471,"Q3SYV4","CAP1_BOVIN","Adenylyl cyclase-associated protein 1 (CAP 1)","GO:0000902; GO:0003779; GO:0005886; GO:0007163; GO:0008154; GO:0008179; GO:0030864","cortical actin cytoskeleton [GO:0030864]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; actin polymerization or depolymerization [GO:0008154]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]"
"37","PGEN_.00g309800","cytoskeletal activity",1.2523505381917e-08,"Scaffold_15",32438370,32567442,"Q9EQW7","KI13A_MOUSE","Kinesin-like protein KIF13A","GO:0003777; GO:0005524; GO:0005623; GO:0005813; GO:0005871; GO:0005874; GO:0006886; GO:0007018; GO:0007049; GO:0008017; GO:0008333; GO:0010008; GO:0016887; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383","cell [GO:0005623]; centrosome [GO:0005813]; endosome membrane [GO:0010008]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459]"
"38","PGEN_.00g330320","cytoskeletal activity",0.000248861681159278,"Scaffold_17",8945788,8999981,"P54288","CACB2_RABIT","Voltage-dependent L-type calcium channel subunit beta-2 (CAB2) (Calcium channel voltage-dependent subunit beta 2)","GO:0007601; GO:0008331; GO:0034765; GO:0051015; GO:0051928; GO:0070509; GO:0086056; GO:0086091; GO:0098684; GO:0098793; GO:0098912; GO:0099635; GO:1990454","L-type voltage-gated calcium channel complex [GO:1990454]; photoreceptor ribbon synapse [GO:0098684]; presynapse [GO:0098793]; actin filament binding [GO:0051015]; high voltage-gated calcium channel activity [GO:0008331]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; calcium ion import [GO:0070509]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; positive regulation of calcium ion transport [GO:0051928]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; visual perception [GO:0007601]"
"39","PGEN_.00g336030","cytoskeletal activity",0.00425581337082155,"Scaffold_17",26753895,26778865,"O88327","CTNL1_MOUSE","Alpha-catulin (Alpha-catenin-related protein) (ACRP) (Catenin alpha-like protein 1)","GO:0005829; GO:0005856; GO:0005886; GO:0007155; GO:0007266; GO:0045296; GO:0051015","cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266]"
"40","PGEN_.00g001170","cytoskeleton",7.46116355541912e-17,"Scaffold_01",2366888,2417042,"Q66HA5","C2D1A_RAT","Coiled-coil and C2 domain-containing protein 1A (Five prime repressor element under dual repression-binding protein 1) (FRE under dual repression-binding protein 1) (Freud-1)","GO:0000122; GO:0000978; GO:0001227; GO:0001650; GO:0005634; GO:0005815; GO:0005829; GO:0005886","cytosol [GO:0005829]; fibrillar center [GO:0001650]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]"
"41","PGEN_.00g005660","cytoskeleton",0.00193871303220277,"Scaffold_01",14272638,14385002,"Q91ZU6","DYST_MOUSE","Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)","GO:0001725; GO:0003779; GO:0005509; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005882; GO:0005925; GO:0005938; GO:0007155; GO:0007409; GO:0008017; GO:0008090; GO:0009898; GO:0014069; GO:0014704; GO:0015629; GO:0015630; GO:0016020; GO:0016021; GO:0030018; GO:0030056; GO:0030424; GO:0031110; GO:0031122; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042383; GO:0042803; GO:0045104; GO:0046907; GO:0048471; GO:0051010; GO:0060053; GO:0097038; GO:1904115","actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; neurofilament cytoskeleton [GO:0060053]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; regulation of microtubule polymerization or depolymerization [GO:0031110]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060]"
"42","PGEN_.00g007340","cytoskeleton",0.00026872587429312,"Scaffold_01",18195064,18316661,"Q08499","PDE4D_HUMAN","cAMP-specific 3',5'-cyclic phosphodiesterase 4D (EC 3.1.4.53) (DPDE3) (PDE43)","GO:0002027; GO:0004114; GO:0004115; GO:0005813; GO:0005829; GO:0005886; GO:0005891; GO:0006198; GO:0006939; GO:0007186; GO:0007568; GO:0008144; GO:0010469; GO:0010880; GO:0016020; GO:0016324; GO:0019899; GO:0019933; GO:0030552; GO:0030593; GO:0031625; GO:0031698; GO:0032729; GO:0032743; GO:0032754; GO:0033137; GO:0034704; GO:0035264; GO:0043951; GO:0044325; GO:0045822; GO:0046872; GO:0050852; GO:0051117; GO:0060314; GO:0061028; GO:0071222; GO:0071320; GO:0071872; GO:0071875; GO:0086004; GO:0086024; GO:0097110; GO:1901844; GO:1901898","apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; ATPase binding [GO:0051117]; beta-2 adrenergic receptor binding [GO:0031698]; cAMP binding [GO:0030552]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate [GO:0086024]; adrenergic receptor signaling pathway [GO:0071875]; aging [GO:0007568]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; G protein-coupled receptor signaling pathway [GO:0007186]; multicellular organism growth [GO:0035264]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of heart contraction [GO:0045822]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of signaling receptor activity [GO:0010469]; smooth muscle contraction [GO:0006939]; T cell receptor signaling pathway [GO:0050852]"
"43","PGEN_.00g014370","cytoskeleton",2.05619911356504e-06,"Scaffold_01",37277926,37336883,"Q11002","CANA_DROME","Calpain-A (EC 3.4.22.-) (Calcium-activated neutral proteinase A) (CANP A) [Cleaved into: Calpain-A catalytic subunit]","GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007520; GO:0008340; GO:0008345; GO:0009953; GO:0015629; GO:0016322; GO:0016540; GO:0042335; GO:0043025; GO:0050832","actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cuticle development [GO:0042335]; defense response to fungus [GO:0050832]; determination of adult lifespan [GO:0008340]; dorsal/ventral pattern formation [GO:0009953]; larval locomotory behavior [GO:0008345]; myoblast fusion [GO:0007520]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]"
"44","PGEN_.00g014630","cytoskeleton",0.034160026851891,"Scaffold_01",38059667,38113107,"Q6ZPV2","INO80_MOUSE","Chromatin-remodeling ATPase INO80 (EC 3.6.4.-) (DNA helicase-related INO80 complex homolog 1) (DNA helicase-related protein INO80)","GO:0000070; GO:0000724; GO:0003677; GO:0003779; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005874; GO:0005886; GO:0006281; GO:0006302; GO:0006338; GO:0006351; GO:0008094; GO:0010571; GO:0016604; GO:0016887; GO:0030307; GO:0031011; GO:0034644; GO:0042393; GO:0042766; GO:0043014; GO:0043044; GO:0043618; GO:0045944; GO:0051225; GO:0051301; GO:0070914; GO:0071479; GO:2000045","cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; nucleosome mobilization [GO:0042766]; positive regulation of cell growth [GO:0030307]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; transcription, DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914]"
"45","PGEN_.00g017860","cytoskeleton",0.0320715779321826,"Scaffold_01",48136795,48272553,"Q9C0G6","DYH6_HUMAN","Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)","GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959","cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
"46","PGEN_.00g025100","cytoskeleton",1.18960913659052e-07,"Scaffold_01",69691912,69771035,"Q8NDI1","EHBP1_HUMAN","EH domain-binding protein 1","GO:0005654; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0006897; GO:0015031; GO:0030036; GO:0031941","cytosol [GO:0005829]; endosome [GO:0005768]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; protein transport [GO:0015031]"
"47","PGEN_.00g028280","cytoskeleton",0.0432844767781971,"Scaffold_01",78164630,78265700,"Q9JHU4","DYHC1_MOUSE","Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)","GO:0000278; GO:0002177; GO:0003341; GO:0005524; GO:0005623; GO:0005635; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007018; GO:0007097; GO:0008090; GO:0008569; GO:0030175; GO:0030286; GO:0030424; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0043025; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0072382; GO:0090235; GO:0120162; GO:1904115; GO:1905832","axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell [GO:0005623]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; dynein complex [GO:0030286]; filopodium [GO:0030175]; manchette [GO:0002177]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cell division [GO:0051301]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; cytoplasmic mRNA processing body assembly [GO:0033962]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; nuclear migration [GO:0007097]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063]"
"48","PGEN_.00g037350","cytoskeleton",0.0216559662646586,"Scaffold_02",11321662,11338493,"Q13257","MD2L1_HUMAN","Mitotic spindle assembly checkpoint protein MAD2A (HsMAD2) (Mitotic arrest deficient 2-like protein 1) (MAD2-like protein 1)","GO:0000070; GO:0000132; GO:0000776; GO:0000777; GO:0000922; GO:0005623; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006511; GO:0007093; GO:0007094; GO:0008022; GO:0031145; GO:0042177; GO:0042802; GO:0042803; GO:0043066; GO:0044615; GO:0045930; GO:0048471; GO:0051301; GO:0051660; GO:0072686; GO:0090267; GO:1901990; GO:1904667","cell [GO:0005623]; chromosome [GO:0005694]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic cell cycle checkpoint [GO:0007093]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of mitotic cell cycle phase transition [GO:1901990]; ubiquitin-dependent protein catabolic process [GO:0006511]"
"49","PGEN_.00g043360","cytoskeleton",0.00026872587429312,"Scaffold_02",28694545,28729634,"A1ZA47","ZASP_DROME","PDZ and LIM domain protein Zasp (Z band alternatively spliced PDZ-motif protein)","GO:0001725; GO:0001952; GO:0003779; GO:0005913; GO:0005915; GO:0005925; GO:0005927; GO:0015629; GO:0016323; GO:0030018; GO:0030036; GO:0030239; GO:0031252; GO:0031941; GO:0042805; GO:0045177; GO:0045178; GO:0046872; GO:0051371; GO:0061061","actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; cell-cell adherens junction [GO:0005913]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952]"
"50","PGEN_.00g047880","cytoskeleton",0.000996571848632056,"Scaffold_02",40918035,40953160,"P57103","NAC3_HUMAN","Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3)","GO:0002244; GO:0005432; GO:0005516; GO:0005623; GO:0005741; GO:0005789; GO:0005874; GO:0005886; GO:0005887; GO:0006811; GO:0006851; GO:0006874; GO:0007154; GO:0007612; GO:0007613; GO:0014819; GO:0016528; GO:0021537; GO:0030054; GO:0031226; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0043197; GO:0043204; GO:0046872; GO:0048471; GO:0048709; GO:0051560; GO:0060291; GO:0070588; GO:0071320; GO:0071456; GO:0098703; GO:0099055; GO:0099580; GO:1903779; GO:1905060; GO:1990034","cell [GO:0005623]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; ion transport [GO:0006811]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of cardiac conduction [GO:1903779]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537]"
"51","PGEN_.00g049510","cytoskeleton",0.00046221698864548,"Scaffold_02",45350315,45373894,"Q8TDM6","DLG5_HUMAN","Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG)","GO:0001837; GO:0005737; GO:0005886; GO:0005913; GO:0007165; GO:0008013; GO:0008092; GO:0008285; GO:0014069; GO:0030011; GO:0030054; GO:0030159; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0035556; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045880; GO:0051965; GO:0060441; GO:0060999; GO:0065003; GO:0071896; GO:0072205; GO:0098609","cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; receptor signaling complex adaptor activity [GO:0030159]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186]"
"52","PGEN_.00g057650","cytoskeleton",0.000376623787655412,"Scaffold_02",68547910,68600615,"Q28205","TBCD_BOVIN","Tubulin-specific chaperone D (Beta-tubulin cofactor D) (Tubulin-folding cofactor D)","GO:0000226; GO:0000278; GO:0005096; GO:0005813; GO:0005829; GO:0005912; GO:0005923; GO:0006457; GO:0007021; GO:0007023; GO:0010812; GO:0016328; GO:0031115; GO:0034333; GO:0048487; GO:0048667; GO:0070830","adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; beta-tubulin binding [GO:0048487]; GTPase activator activity [GO:0005096]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021]"
"53","PGEN_.00g066340","cytoskeleton",0.000112044076940847,"Scaffold_03",23576108,23642329,"A2ASS6","TITIN_MOUSE","Titin (EC 2.7.11.1) (Connectin)","GO:0000794; GO:0001701; GO:0001756; GO:0002020; GO:0003007; GO:0003300; GO:0004674; GO:0004713; GO:0005200; GO:0005509; GO:0005516; GO:0005524; GO:0005859; GO:0005865; GO:0006936; GO:0007507; GO:0007512; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0021591; GO:0030016; GO:0030017; GO:0030018; GO:0030240; GO:0030241; GO:0030506; GO:0031430; GO:0031433; GO:0031672; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043056; GO:0043621; GO:0045214; GO:0045859; GO:0048739; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055002; GO:0055003; GO:0055008; GO:0060048; GO:0060419; GO:0071688; GO:1901897","A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591]"
"54","PGEN_.00g070550","cytoskeleton",0.0477752922441708,"Scaffold_03",34930040,35036210,"Q9CZ62","CEP97_MOUSE","Centrosomal protein of 97 kDa (Cep97) (Leucine-rich repeat and IQ domain-containing protein 2)","GO:0005813; GO:0005829; GO:0030030; GO:0032991; GO:0034451; GO:1901673; GO:1902018","centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of mitotic spindle assembly [GO:1901673]"
"55","PGEN_.00g072570","cytoskeleton",0.0157659660818071,"Scaffold_03",40880605,40920244,"O95835","LATS1_HUMAN","Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts)","GO:0000082; GO:0000086; GO:0000287; GO:0000819; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005815; GO:0005829; GO:0006468; GO:0009755; GO:0018105; GO:0019901; GO:0030216; GO:0030331; GO:0030833; GO:0033138; GO:0033146; GO:0034613; GO:0035329; GO:0035556; GO:0043065; GO:0043254; GO:0045736; GO:0046620; GO:0051220; GO:0051301; GO:0060644; GO:0090090; GO:2000058","cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cellular protein localization [GO:0034613]; cytoplasmic sequestering of protein [GO:0051220]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of protein complex assembly [GO:0043254]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819]"
"56","PGEN_.00g081000","cytoskeleton",5.71559959478455e-05,"Scaffold_04",6562308,6600640,"Q27802","DYHC2_TRIGR","Cytoplasmic dynein 2 heavy chain 1 (Dynein heavy chain isotype 1B)","GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005886; GO:0005929; GO:0007018; GO:0007275; GO:0030030; GO:0030286","cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; multicellular organism development [GO:0007275]"
"57","PGEN_.00g082390","cytoskeleton",0.0355587663372623,"Scaffold_04",9894020,9900405,"Q8BR93","HARB1_MOUSE","Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)","GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872","centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]"
"58","PGEN_.00g085220","cytoskeleton",0.02778033687098,"Scaffold_04",16443385,16457022,"P82349","SGCB_MOUSE","Beta-sarcoglycan (Beta-SG) (43 kDa dystrophin-associated glycoprotein) (43DAG)","GO:0005737; GO:0005856; GO:0005886; GO:0005887; GO:0007517; GO:0016010; GO:0016011; GO:0016012; GO:0042383; GO:0048747; GO:0055013; GO:0061024; GO:0097084","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]; cardiac muscle cell development [GO:0055013]; membrane organization [GO:0061024]; muscle fiber development [GO:0048747]; muscle organ development [GO:0007517]; vascular smooth muscle cell development [GO:0097084]"
"59","PGEN_.00g087190","cytoskeleton",0.0498717034005176,"Scaffold_04",21975367,22078490,"O75592","MYCB2_HUMAN","E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.-) (Myc-binding protein 2) (Protein associated with Myc)","GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008536; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042803; GO:0043231; GO:0050905; GO:0051493; GO:0061630; GO:1902667","axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein homodimerization activity [GO:0042803]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]"
"60","PGEN_.00g102230","cytoskeleton",0.0237400607993744,"Scaffold_04",61170576,61178433,"Q9R1K9","CETN2_MOUSE","Centrin-2 (Caltractin isoform 1)","GO:0000278; GO:0005509; GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0006289; GO:0007099; GO:0007283; GO:0008017; GO:0015031; GO:0031683; GO:0032391; GO:0032465; GO:0032795; GO:0036064; GO:0044615; GO:0051028; GO:0051301; GO:0070390; GO:0071942","centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390]; XPC complex [GO:0071942]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017]; cell division [GO:0051301]; centriole replication [GO:0007099]; mitotic cell cycle [GO:0000278]; mRNA transport [GO:0051028]; nucleotide-excision repair [GO:0006289]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283]"
"61","PGEN_.00g110260","cytoskeleton",4.43673910783518e-05,"Scaffold_05",15669855,15764255,"Q39565","DYHB_CHLRE","Dynein beta chain, flagellar outer arm","GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0030030; GO:0030286; GO:0031514","cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]"
"62","PGEN_.00g111670","cytoskeleton",0.0126095904962081,"Scaffold_05",20031909,20049836,"Q9H892","TTC12_HUMAN","Tetratricopeptide repeat protein 12 (TPR repeat protein 12)","GO:0005813","centrosome [GO:0005813]"
"63","PGEN_.00g130160","cytoskeleton",0.0222295668663508,"Scaffold_06",3270606,3274261,"Q8BR93","HARB1_MOUSE","Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease)","GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872","centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]"
"64","PGEN_.00g137740","cytoskeleton",0.0381511639601278,"Scaffold_06",21514369,21521149,"Q8VDN4","CCD92_MOUSE","Coiled-coil domain-containing protein 92","GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0043231","centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]"
"65","PGEN_.00g151360","cytoskeleton",0.0301793441062283,"Scaffold_06",57783330,57868391,"Q9JMH9","MY18A_MOUSE","Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210)","GO:0000139; GO:0005524; GO:0005793; GO:0005802; GO:0005856; GO:0005903; GO:0007030; GO:0016459; GO:0016477; GO:0030054; GO:0031032; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0045202; GO:0045335; GO:0048194; GO:0050714; GO:0051015; GO:0071346; GO:0090161; GO:0090164; GO:1903028","actomyosin [GO:0042641]; brush border [GO:0005903]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; myosin complex [GO:0016459]; phagocytic vesicle [GO:0045335]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]"
"66","PGEN_.00g153140","cytoskeleton",0.0214094479527275,"Scaffold_07",1037155,1079880,"Q12955","ANK3_HUMAN","Ankyrin-3 (ANK-3) (Ankyrin-G)","GO:0000281; GO:0005200; GO:0005623; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0007009; GO:0007016; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016020; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259","axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding, bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; cytoskeletal anchoring at plasma membrane [GO:0007016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]"
"67","PGEN_.00g155550","cytoskeleton",0.0203700145033832,"Scaffold_07",7853488,7891685,"O14514","AGRB1_HUMAN","Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)]","GO:0001530; GO:0001786; GO:0001891; GO:0004930; GO:0005615; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0006910; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007189; GO:0007409; GO:0007422; GO:0007517; GO:0008285; GO:0010596; GO:0014069; GO:0016021; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051965; GO:1901741; GO:1903428","cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]"
"68","PGEN_.00g159920","cytoskeleton",0.000608858996323151,"Scaffold_07",20096094,20100380,"P24587","AKAP5_RAT","A-kinase anchor protein 5 (AKAP-5) (A-kinase anchor protein 150 kDa) (AKAP 150) (P150) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein)","GO:0001664; GO:0001934; GO:0003779; GO:0005516; GO:0005623; GO:0005737; GO:0005856; GO:0005886; GO:0006605; GO:0007193; GO:0007194; GO:0008179; GO:0009898; GO:0010524; GO:0010738; GO:0014069; GO:0014850; GO:0016323; GO:0017124; GO:0019900; GO:0019901; GO:0019904; GO:0021510; GO:0021766; GO:0030346; GO:0030425; GO:0031527; GO:0031698; GO:0032279; GO:0032590; GO:0032591; GO:0032991; GO:0034237; GO:0035254; GO:0036394; GO:0042307; GO:0043025; GO:0043197; GO:0043198; GO:0043267; GO:0043271; GO:0043624; GO:0044877; GO:0045121; GO:0045296; GO:0045762; GO:0048471; GO:0050775; GO:0050811; GO:0051602; GO:0060076; GO:0060090; GO:0060135; GO:0070886; GO:0071417; GO:0097110; GO:0098978; GO:0099092; GO:0099149; GO:1903078","asymmetric synapse [GO:0032279]; basolateral plasma membrane [GO:0016323]; cell [GO:0005623]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; excitatory synapse [GO:0060076]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; G protein-coupled receptor binding [GO:0001664]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; amylase secretion [GO:0036394]; cellular protein complex disassembly [GO:0043624]; cellular response to organonitrogen compound [GO:0071417]; hippocampus development [GO:0021766]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of ion transport [GO:0043271]; negative regulation of potassium ion transport [GO:0043267]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein targeting [GO:0006605]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein kinase A signaling [GO:0010738]; response to electrical stimulus [GO:0051602]; response to muscle activity [GO:0014850]; spinal cord development [GO:0021510]"
"69","PGEN_.00g164740","cytoskeleton",0.0185970418706249,"Scaffold_07",32879160,32939450,"Q86VH2","KIF27_HUMAN","Kinesin-like protein KIF27","GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0021591; GO:0060271","cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591]"
"70","PGEN_.00g171340","cytoskeleton",0.0301793441062283,"Scaffold_08",8392053,8447234,"O43312","MTSS1_HUMAN","Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein)","GO:0001726; GO:0003785; GO:0005102; GO:0005737; GO:0007009; GO:0007155; GO:0007169; GO:0015629; GO:0030035; GO:0030036; GO:0030139; GO:0042802; GO:0050680; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:2001013","actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"
"71","PGEN_.00g171350","cytoskeleton",0.0120620312575807,"Scaffold_08",8447286,8475295,"Q8R1S4","MTSS1_MOUSE","Protein MTSS 1 (Metastasis suppressor protein 1) (Missing in metastasis protein)","GO:0001701; GO:0003779; GO:0003785; GO:0005102; GO:0005737; GO:0005912; GO:0007009; GO:0007015; GO:0007399; GO:0007517; GO:0010960; GO:0015629; GO:0030041; GO:0030282; GO:0032233; GO:0034334; GO:0042802; GO:0050680; GO:0051015; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:0072170; GO:2001013","actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; adherens junction maintenance [GO:0034334]; bone mineralization [GO:0030282]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; in utero embryonic development [GO:0001701]; magnesium ion homeostasis [GO:0010960]; metanephric tubule development [GO:0072170]; muscle organ development [GO:0007517]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; plasma membrane organization [GO:0007009]; positive regulation of actin filament bundle assembly [GO:0032233]; renal tubule morphogenesis [GO:0061333]"
"72","PGEN_.00g173900","cytoskeleton",0.0266554609311605,"Scaffold_08",16092145,16140217,"Q8CG73","FTM_MOUSE","Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein) (RPGRIP1-like protein)","GO:0001701; GO:0001736; GO:0001822; GO:0001889; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005879; GO:0005886; GO:0005911; GO:0005923; GO:0005929; GO:0005930; GO:0007163; GO:0007368; GO:0007420; GO:0008589; GO:0021532; GO:0021537; GO:0021549; GO:0021670; GO:0021772; GO:0022038; GO:0031870; GO:0032391; GO:0035108; GO:0035115; GO:0035116; GO:0035253; GO:0035869; GO:0036064; GO:0043010; GO:0043584; GO:0045744; GO:0060039; GO:0060271; GO:0060322; GO:0090102; GO:1905515","axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; thromboxane A2 receptor binding [GO:0031870]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; limb morphogenesis [GO:0035108]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; telencephalon development [GO:0021537]"
"73","PGEN_.00g190430","cytoskeleton",0.0364649592744605,"Scaffold_08",59613122,59676228,"O75096","LRP4_HUMAN","Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7)","GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0051290; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395","cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055]"
"74","PGEN_.00g206810","cytoskeleton",4.5224399725376e-05,"Scaffold_10",7584310,7700085,"Q8BW94","DYH3_MOUSE","Dynein heavy chain 3, axonemal (Axonemal beta dynein heavy chain 3) (Ciliary dynein heavy chain 3)","GO:0003341; GO:0005524; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045505; GO:0051959","dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018]"
"75","PGEN_.00g211830","cytoskeleton",8.33429332391007e-06,"Scaffold_10",21025397,21043857,"P16056","MET_MOUSE","Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)","GO:0000122; GO:0000187; GO:0001764; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0004713; GO:0004714; GO:0005008; GO:0005524; GO:0005615; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0008013; GO:0009925; GO:0010628; GO:0010629; GO:0010800; GO:0010801; GO:0010828; GO:0010976; GO:0014069; GO:0014812; GO:0014902; GO:0016020; GO:0017154; GO:0019903; GO:0030182; GO:0030317; GO:0030425; GO:0030534; GO:0031016; GO:0031116; GO:0032675; GO:0033138; GO:0035024; GO:0036126; GO:0042593; GO:0042802; GO:0043005; GO:0043025; GO:0043235; GO:0043274; GO:0043548; GO:0044877; GO:0045211; GO:0045740; GO:0045840; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050775; GO:0050804; GO:0050918; GO:0051450; GO:0051497; GO:0051897; GO:0055013; GO:0060048; GO:0060076; GO:0060079; GO:0060665; GO:0061436; GO:0070495; GO:0071526; GO:0071635; GO:0072593; GO:1900407; GO:1900745; GO:1901299; GO:1905098; GO:2001028","basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; hepatocyte growth factor-activated receptor activity [GO:0005008]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase binding [GO:0043548]; phospholipase binding [GO:0043274]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; establishment of skin barrier [GO:0061436]; excitatory postsynaptic potential [GO:0060079]; flagellated sperm motility [GO:0030317]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of chemical synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta production [GO:0071635]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; pancreas development [GO:0031016]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neuron projection development [GO:0010976]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]"
"76","PGEN_.00g226840","cytoskeleton",0.0145479681407003,"Scaffold_11",7272683,7370846,"Q9VEN1","FLNA_DROME","Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Filamin-1) (Filamin1)","GO:0000278; GO:0003779; GO:0005829; GO:0005886; GO:0007301; GO:0007303; GO:0007616; GO:0008045; GO:0008104; GO:0008302; GO:0008340; GO:0015629; GO:0030018; GO:0030708; GO:0030725; GO:0035182; GO:0035183; GO:0035204; GO:0035324; GO:0045179; GO:0045214; GO:0048149; GO:0051495","actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport, nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation, actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214]"
"77","PGEN_.00g227520","cytoskeleton",0.0382379150397033,"Scaffold_11",9517456,9568849,"Q17LW0","MYO7A_AEDAE","Myosin-VIIa (Protein crinkled)","GO:0003774; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0030898; GO:0032027; GO:0035317; GO:0048800; GO:0051015","cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]"
"78","PGEN_.00g233580","cytoskeleton",0.0404096067229422,"Scaffold_11",27099534,27108460,"P68372","TBB4B_MOUSE","Tubulin beta-4B chain (Tubulin beta-2C chain)","GO:0000226; GO:0000278; GO:0003725; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0043209; GO:0045298","cytoplasm [GO:0005737]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; tubulin complex [GO:0045298]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]"
"79","PGEN_.00g233770","cytoskeleton",0.000794258264075605,"Scaffold_11",27658467,27661179,"P11833","TBB_PARLI","Tubulin beta chain (Beta-tubulin)","GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017","cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017]"
"80","PGEN_.00g242340","cytoskeleton",0.00439561497746984,"Scaffold_11",51359268,51378202,"Q01705","NOTC1_MOUSE","Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]","GO:0000122; GO:0000139; GO:0000978; GO:0001228; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003256; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003700; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005887; GO:0005912; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0043065; GO:0043086; GO:0043235; GO:0043565; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0045967; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050434; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060411; GO:0060412; GO:0060528; GO:0060548; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061344; GO:0061384; GO:0061419; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071372; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072602; GO:0090051; GO:0090090; GO:0097150; GO:0120163; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000737; GO:2000811; GO:2000974; GO:2001027","acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"
"81","PGEN_.00g256280","cytoskeleton",0.00438032260364062,"Scaffold_12",41267609,41297324,"O95786","DDX58_HUMAN","Antiviral innate immune response receptor RIG-I (DEAD box protein 58) (Probable ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (RIG-I-like receptor 1) (RLR-1) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I)","GO:0002230; GO:0002735; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010628; GO:0015629; GO:0016032; GO:0016579; GO:0030334; GO:0031625; GO:0032480; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0034344; GO:0035549; GO:0039528; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051091; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1902741; GO:1904469; GO:1990904; GO:2000778","actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; negative regulation of type I interferon production [GO:0032480]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein deubiquitination [GO:0016579]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]; viral process [GO:0016032]"
"82","PGEN_.00g264510","cytoskeleton",0.0312091287925959,"Scaffold_13",13027439,13131780,"P83038","HDAC4_CHICK","Histone deacetylase 4 (HD4) (EC 3.5.1.98)","GO:0000118; GO:0000978; GO:0001085; GO:0001501; GO:0002076; GO:0003682; GO:0003714; GO:0004407; GO:0005829; GO:0006325; GO:0006338; GO:0006954; GO:0007399; GO:0008134; GO:0008270; GO:0008284; GO:0008285; GO:0010832; GO:0010882; GO:0014894; GO:0016607; GO:0017053; GO:0019901; GO:0030183; GO:0030955; GO:0031594; GO:0032041; GO:0033235; GO:0033613; GO:0034983; GO:0040029; GO:0042113; GO:0042641; GO:0042802; GO:0042826; GO:0043393; GO:0043433; GO:0045668; GO:0045820; GO:0045843; GO:0045892; GO:0045944; GO:0048742; GO:0051091; GO:0070491; GO:0070555; GO:0070933; GO:1902894","actomyosin [GO:0042641]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; potassium ion binding [GO:0030955]; protein kinase binding [GO:0019901]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]"
"83","PGEN_.00g268760","cytoskeleton",0.000115272590621004,"Scaffold_13",25183636,25193923,"Q9EQZ6","RPGF4_MOUSE","Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-dependent Rap1 guanine-nucleotide exchange factor) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII)","GO:0001750; GO:0001917; GO:0005085; GO:0005088; GO:0005829; GO:0005886; GO:0005903; GO:0005929; GO:0007165; GO:0007264; GO:0014069; GO:0014911; GO:0016323; GO:0016324; GO:0017016; GO:0017156; GO:0017157; GO:0019933; GO:0030073; GO:0030424; GO:0030425; GO:0030426; GO:0030552; GO:0032991; GO:0043025; GO:0043197; GO:0044316; GO:0044877; GO:0050714; GO:0050773; GO:0050805; GO:0060076; GO:0098686; GO:0098693; GO:0098696; GO:0098978; GO:0099175; GO:1904457","apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cilium [GO:0005929]; cone cell pedicle [GO:0044316]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]; Ras GTPase binding [GO:0017016]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; calcium-ion regulated exocytosis [GO:0017156]; cAMP-mediated signaling [GO:0019933]; insulin secretion [GO:0030073]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of protein secretion [GO:0050714]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of dendrite development [GO:0050773]; regulation of exocytosis [GO:0017157]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of postsynapse organization [GO:0099175]; regulation of synaptic vesicle cycle [GO:0098693]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]"
"84","PGEN_.00g269010","cytoskeleton",0.0234220924480779,"Scaffold_13",25828377,25913057,"Q8TEW0","PARD3_HUMAN","Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha)","GO:0000226; GO:0005546; GO:0005547; GO:0005623; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005912; GO:0005913; GO:0005923; GO:0005938; GO:0006612; GO:0007049; GO:0007155; GO:0007163; GO:0007179; GO:0007205; GO:0007409; GO:0008104; GO:0008356; GO:0010801; GO:0012505; GO:0016324; GO:0019903; GO:0022011; GO:0030010; GO:0030054; GO:0031643; GO:0032266; GO:0032991; GO:0033269; GO:0035091; GO:0036464; GO:0042802; GO:0043025; GO:0043296; GO:0044295; GO:0045197; GO:0051660; GO:0060341; GO:0065003; GO:0070830; GO:0090162","adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell [GO:0005623]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein phosphatase binding [GO:0019903]; asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; protein-containing complex assembly [GO:0065003]; regulation of cellular localization [GO:0060341]; transforming growth factor beta receptor signaling pathway [GO:0007179]"
"85","PGEN_.00g269250","cytoskeleton",0.0123408049362014,"Scaffold_13",26552097,26588309,"Q9JJK2","LANC2_MOUSE","LanC-like protein 2 (Testis-specific adriamycin sensitivity protein)","GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0009789; GO:0010314; GO:0030864; GO:0032266; GO:0045892; GO:0070273","cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]"
"86","PGEN_.00g270640","cytoskeleton",0.0220809249535981,"Scaffold_13",30124160,30148040,"Q2KID4","DNAL1_BOVIN","Dynein light chain 1, axonemal","GO:0003774; GO:0005737; GO:0005874; GO:0030286; GO:0036158; GO:0042995; GO:0043014; GO:0045504","cell projection [GO:0042995]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; outer dynein arm assembly [GO:0036158]"
"87","PGEN_.00g274530","cytoskeleton",0.000782221588868464,"Scaffold_13",40767020,40771439,"P06603","TBA1_DROME","Tubulin alpha-1 chain","GO:0000226; GO:0000235; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007017; GO:0032418; GO:0048471","astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]"
"88","PGEN_.00g277430","cytoskeleton",2.00165589730783e-08,"Scaffold_14",3442934,3496237,"Q7Z7A1","CNTRL_HUMAN","Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110)","GO:0000086; GO:0005813; GO:0005815; GO:0005829; GO:0008092; GO:0010389; GO:0016020; GO:0051301; GO:0051493; GO:0090543; GO:0097711; GO:0120103","centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; cytoskeletal protein binding [GO:0008092]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of cytoskeleton organization [GO:0051493]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]"
"89","PGEN_.00g278620","cytoskeleton",0.00345255415974166,"Scaffold_14",6014261,6046448,"Q8K389","CK5P2_MOUSE","CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48)","GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0001578; GO:0005516; GO:0005623; GO:0005737; GO:0005794; GO:0005813; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0008274; GO:0015631; GO:0019901; GO:0022008; GO:0030054; GO:0031023; GO:0031116; GO:0035371; GO:0043015; GO:0044212; GO:0044877; GO:0045665; GO:0045893; GO:0046600; GO:0048471; GO:0090266; GO:0097431","cell [GO:0005623]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; gamma-tubulin ring complex [GO:0008274]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription regulatory region DNA binding [GO:0044212]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]"
"90","PGEN_.00g280420","cytoskeleton",0.0143882069404294,"Scaffold_14",10224525,10287990,"Q5T4S7","UBR4_HUMAN","E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1)","GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0016021; GO:0016032; GO:0035579; GO:0043312; GO:0070821; GO:0101003","centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]"
"91","PGEN_.00g284620","cytoskeleton",0.019648332519261,"Scaffold_14",20735108,20737187,"Q9C0G6","DYH6_HUMAN","Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)","GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959","cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
"92","PGEN_.00g289090","cytoskeleton",2.79663988445674e-05,"Scaffold_14",29650979,29662232,"E9Q5G3","KIF23_MOUSE","Kinesin-like protein KIF23","GO:0000281; GO:0000915; GO:0003777; GO:0005524; GO:0005623; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0045171; GO:0051256; GO:0072383; GO:0072686; GO:0090543; GO:0097149","cell [GO:0005623]; centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; actomyosin contractile ring assembly [GO:0000915]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]"
"93","PGEN_.00g290400","cytoskeleton",0.0413023675513884,"Scaffold_14",32684479,32694765,"Q9C0G6","DYH6_HUMAN","Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)","GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959","cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity, minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]"
"94","PGEN_.00g291980","cytoskeleton",0.0295186578593357,"Scaffold_14",36100269,36171829,"Q5U3Q6","CIP4_DANRE","Cdc42-interacting protein 4 homolog (Thyroid receptor-interacting protein 10 homolog)","GO:0005764; GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0008289; GO:0030036","cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]"
"95","PGEN_.00g301440","cytoskeleton",0.00430436072419834,"Scaffold_15",10886361,10928410,"Q5T5Y3","CAMP1_HUMAN","Calmodulin-regulated spectrin-associated protein 1","GO:0000226; GO:0005516; GO:0005737; GO:0005874; GO:0007010; GO:0007026; GO:0008017; GO:0022604; GO:0030507; GO:0031113; GO:0031122; GO:0031175; GO:0051011","cytoplasm [GO:0005737]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113]"
"96","PGEN_.00g306890","cytoskeleton",0.0161087084801812,"Scaffold_15",24511937,24569471,"Q3SYV4","CAP1_BOVIN","Adenylyl cyclase-associated protein 1 (CAP 1)","GO:0000902; GO:0003779; GO:0005886; GO:0007163; GO:0008154; GO:0008179; GO:0030864","cortical actin cytoskeleton [GO:0030864]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; actin polymerization or depolymerization [GO:0008154]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]"
"97","PGEN_.00g309800","cytoskeleton",1.2523505381917e-08,"Scaffold_15",32438370,32567442,"Q9EQW7","KI13A_MOUSE","Kinesin-like protein KIF13A","GO:0003777; GO:0005524; GO:0005623; GO:0005813; GO:0005871; GO:0005874; GO:0006886; GO:0007018; GO:0007049; GO:0008017; GO:0008333; GO:0010008; GO:0016887; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383","cell [GO:0005623]; centrosome [GO:0005813]; endosome membrane [GO:0010008]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459]"
"98","PGEN_.00g312300","cytoskeleton",0.0251401119320496,"Scaffold_15",39020553,39070876,"Q9BTC0","DIDO1_HUMAN","Death-inducer obliterator 1 (DIO-1) (hDido1) (Death-associated transcription factor 1) (DATF-1)","GO:0003723; GO:0005634; GO:0005737; GO:0005819; GO:0006351; GO:0046872; GO:0097190","cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; apoptotic signaling pathway [GO:0097190]; transcription, DNA-templated [GO:0006351]"
"99","PGEN_.00g321190","cytoskeleton",0.0103528057064024,"Scaffold_16",14739729,14789048,"Q8JZW5","SH2D5_MOUSE","SH2 domain-containing protein 5","GO:0014069; GO:0030054","cell junction [GO:0030054]; postsynaptic density [GO:0014069]"
"100","PGEN_.00g336030","cytoskeleton",0.00425581337082155,"Scaffold_17",26753895,26778865,"O88327","CTNL1_MOUSE","Alpha-catulin (Alpha-catenin-related protein) (ACRP) (Catenin alpha-like protein 1)","GO:0005829; GO:0005856; GO:0005886; GO:0007155; GO:0007266; GO:0045296; GO:0051015","cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266]"
"101","PGEN_.00g005280","nucleic acid binding activity",0.0139769081812467,"Scaffold_01",13451900,13458859,"P10394","POL4_DROME","Retrovirus-related Pol polyprotein from transposon 412 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","GO:0003676; GO:0003964; GO:0004190; GO:0004519; GO:0015074","aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074]"
"102","PGEN_.00g009310","nucleic acid binding activity",0.00514237843453836,"Scaffold_01",24192615,24221593,"P48380","RFX3_HUMAN","Transcription factor RFX3 (Regulatory factor X 3)","GO:0000790; GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005576; GO:0005634; GO:0005667; GO:0006351; GO:0006355; GO:0006357; GO:0031018; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0048469; GO:0050796; GO:0060271; GO:0060285; GO:0060287; GO:0072560; GO:2000078","extracellular region [GO:0005576]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; cell maturation [GO:0048469]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; endocrine pancreas development [GO:0031018]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type B pancreatic cell development [GO:2000078]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]; type B pancreatic cell maturation [GO:0072560]"
"103","PGEN_.00g010490","nucleic acid binding activity",0.0291474879018234,"Scaffold_01",27804483,27823230,"Q9H074","PAIP1_HUMAN","Polyadenylate-binding protein-interacting protein 1 (PABP-interacting protein 1) (PAIP-1) (Poly(A)-binding protein-interacting protein 1)","GO:0003723; GO:0005737; GO:0005829; GO:0006413; GO:0006446; GO:0008494; GO:0048255","cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; mRNA stabilization [GO:0048255]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]"
"104","PGEN_.00g014630","nucleic acid binding activity",0.034160026851891,"Scaffold_01",38059667,38113107,"Q6ZPV2","INO80_MOUSE","Chromatin-remodeling ATPase INO80 (EC 3.6.4.-) (DNA helicase-related INO80 complex homolog 1) (DNA helicase-related protein INO80)","GO:0000070; GO:0000724; GO:0003677; GO:0003779; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005874; GO:0005886; GO:0006281; GO:0006302; GO:0006338; GO:0006351; GO:0008094; GO:0010571; GO:0016604; GO:0016887; GO:0030307; GO:0031011; GO:0034644; GO:0042393; GO:0042766; GO:0043014; GO:0043044; GO:0043618; GO:0045944; GO:0051225; GO:0051301; GO:0070914; GO:0071479; GO:2000045","cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; nucleosome mobilization [GO:0042766]; positive regulation of cell growth [GO:0030307]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; transcription, DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914]"
"105","PGEN_.00g020710","nucleic acid binding activity",0.0117678474191726,"Scaffold_01",56406454,56420844,"Q13686","ALKB1_HUMAN","Nucleic acid dioxygenase ALKBH1 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 1) (Alpha-ketoglutarate-dependent dioxygenase ABH1) (DNA 6mA demethylase) (DNA N6-methyl adenine demethylase ALKBH1) (EC 1.14.11.51) (DNA lyase ABH1) (EC 4.2.99.18) (DNA oxidative demethylase ALKBH1) (EC 1.14.11.33) (mRNA N(3)-methylcytidine demethylase) (EC 1.14.11.-)","GO:0000049; GO:0001701; GO:0001764; GO:0001890; GO:0002101; GO:0005654; GO:0005719; GO:0005739; GO:0005783; GO:0006281; GO:0006307; GO:0006446; GO:0006448; GO:0008198; GO:0016706; GO:0031175; GO:0035513; GO:0035515; GO:0035516; GO:0042056; GO:0042245; GO:0043524; GO:0048589; GO:0070129; GO:0070579; GO:0070989; GO:0080111; GO:0103053; GO:0140078; GO:1990983; GO:1990984","endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; 1-ethyladenine demethylase activity [GO:0103053]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chemoattractant activity [GO:0042056]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; ferrous iron binding [GO:0008198]; methylcytosine dioxygenase activity [GO:0070579]; oxidative DNA demethylase activity [GO:0035516]; oxidative RNA demethylase activity [GO:0035515]; tRNA binding [GO:0000049]; tRNA demethylase activity [GO:1990984]; developmental growth [GO:0048589]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA demethylation [GO:0080111]; DNA repair [GO:0006281]; in utero embryonic development [GO:0001701]; negative regulation of neuron apoptotic process [GO:0043524]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oxidative demethylation [GO:0070989]; oxidative RNA demethylation [GO:0035513]; placenta development [GO:0001890]; regulation of mitochondrial translation [GO:0070129]; regulation of translational elongation [GO:0006448]; regulation of translational initiation [GO:0006446]; RNA repair [GO:0042245]; tRNA demethylation [GO:1990983]; tRNA wobble cytosine modification [GO:0002101]"
"106","PGEN_.00g022920","nucleic acid binding activity",0.0477377655623547,"Scaffold_01",62808435,62831050,"Q502K2","SAMH1_DANRE","Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-)","GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0090501; GO:0110025","nucleus [GO:0005634]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446]"
"107","PGEN_.00g031690","nucleic acid binding activity",0.0373762414506607,"Scaffold_01",86472181,86475050,"Q80TC5","POGK_MOUSE","Pogo transposable element with KRAB domain","GO:0003677; GO:0005634; GO:0006355; GO:0007275","nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
"108","PGEN_.00g031700","nucleic acid binding activity",0.000924590213329938,"Scaffold_01",86475081,86479781,"Q80TC5","POGK_MOUSE","Pogo transposable element with KRAB domain","GO:0003677; GO:0005634; GO:0006355; GO:0007275","nucleus [GO:0005634]; DNA binding [GO:0003677]; multicellular organism development [GO:0007275]; regulation of transcription, DNA-templated [GO:0006355]"
"109","PGEN_.00g050270","nucleic acid binding activity",0.0131993181259566,"Scaffold_02",47462804,47517164,"P59759","MRTFB_MOUSE","Myocardin-related transcription factor B (MRTF-B) (MKL/myocardin-like protein 2)","GO:0001701; GO:0001764; GO:0001889; GO:0003007; GO:0003700; GO:0003713; GO:0003779; GO:0005634; GO:0005737; GO:0007507; GO:0007517; GO:0010467; GO:0010468; GO:0030036; GO:0030900; GO:0031175; GO:0045844; GO:0045893; GO:0045944; GO:0048514; GO:0048568; GO:0048738; GO:0051145","cytoplasm [GO:0005737]; nucleus [GO:0005634]; actin binding [GO:0003779]; DNA-binding transcription factor activity [GO:0003700]; transcription coactivator activity [GO:0003713]; actin cytoskeleton organization [GO:0030036]; blood vessel morphogenesis [GO:0048514]; cardiac muscle tissue development [GO:0048738]; embryonic organ development [GO:0048568]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; muscle organ development [GO:0007517]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; smooth muscle cell differentiation [GO:0051145]"
"110","PGEN_.00g055620","nucleic acid binding activity",5.4380359755602e-08,"Scaffold_02",62591387,62610230,"Q5R452","SAFB1_PONAB","Scaffold attachment factor B1 (SAF-B1)","GO:0000978; GO:0003682; GO:0003723; GO:0005634; GO:0006355; GO:0050684","nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of mRNA processing [GO:0050684]; regulation of transcription, DNA-templated [GO:0006355]"
"111","PGEN_.00g063490","nucleic acid binding activity",0.000867028768281824,"Scaffold_03",15302111,15305973,"Q09575","YRD6_CAEEL","Uncharacterized protein K02A2.6","GO:0003676; GO:0008270; GO:0015074","nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]"
"112","PGEN_.00g072250","nucleic acid binding activity",0.0200406669957295,"Scaffold_03",40122015,40148532,"Q66J74","TFP11_XENLA","Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1)","GO:0003676; GO:0005681; GO:0006397; GO:0008380","spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]"
"113","PGEN_.00g075800","nucleic acid binding activity",0.00149799258927127,"Scaffold_03",50978634,51016030,"O60293","ZC3H1_HUMAN","Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2)","GO:0000178; GO:0003723; GO:0005615; GO:0005634; GO:0006396; GO:0046872","exosome (RNase complex) [GO:0000178]; extracellular space [GO:0005615]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA processing [GO:0006396]"
"114","PGEN_.00g076410","nucleic acid binding activity",0.0187204649560373,"Scaffold_03",52646062,52715313,"Q60636","PRDM1_MOUSE","PR domain zinc finger protein 1 (EC 2.1.1.-) (B lymphocyte-induced maturation protein 1) (Blimp-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1)","GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0001701; GO:0001763; GO:0001892; GO:0001893; GO:0002250; GO:0003170; GO:0003279; GO:0003281; GO:0003700; GO:0005634; GO:0005737; GO:0007281; GO:0008168; GO:0009791; GO:0010628; GO:0010629; GO:0030889; GO:0031490; GO:0031665; GO:0032259; GO:0032823; GO:0033082; GO:0035904; GO:0042127; GO:0042462; GO:0042826; GO:0043565; GO:0045087; GO:0045165; GO:0045579; GO:0046872; GO:0048844; GO:0051136; GO:0060576; GO:0060707; GO:0060976; GO:1990654; GO:1990841","cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cardiac septum development [GO:0003279]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; embryonic placenta development [GO:0001892]; eye photoreceptor cell development [GO:0042462]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; maternal placenta development [GO:0001893]; methylation [GO:0032259]; morphogenesis of a branching structure [GO:0001763]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of gene expression [GO:0010629]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]"
"115","PGEN_.00g076500","nucleic acid binding activity",0.0295186578593357,"Scaffold_03",52924554,52945335,"Q9UPN6","SCAF8_HUMAN","SR-related and CTD-associated factor 8 (CDC5L complex-associated protein 7) (RNA-binding motif protein 16)","GO:0000993; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005849; GO:0006369; GO:0006378; GO:0016363; GO:0032786; GO:0043175; GO:1990269; GO:2000805","cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; RNA polymerase II complex binding [GO:0000993]; mRNA polyadenylation [GO:0006378]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; termination of RNA polymerase II transcription [GO:0006369]"
"116","PGEN_.00g080210","nucleic acid binding activity",0.000172964989415348,"Scaffold_04",4378335,4411462,"Q9CQN1","TRAP1_MOUSE","Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)","GO:0003723; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0019901; GO:0051082; GO:1901856; GO:1903751","mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; translational attenuation [GO:0009386]"
"117","PGEN_.00g119200","nucleic acid binding activity",0.0413280284106117,"Scaffold_05",41854407,41873229,"A1A4K8","U2AF1_BOVIN","Splicing factor U2AF 35 kDa subunit (U2 auxiliary factor 35 kDa subunit) (U2 snRNP auxiliary factor small subunit)","GO:0000398; GO:0005681; GO:0016607; GO:0030628; GO:0046872; GO:0050733; GO:0089701","nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2AF [GO:0089701]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; RS domain binding [GO:0050733]; mRNA splicing, via spliceosome [GO:0000398]"
"118","PGEN_.00g119570","nucleic acid binding activity",0.00916941597534407,"Scaffold_05",42587867,42621142,"Q924A2","CIC_MOUSE","Protein capicua homolog","GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0007420; GO:0007612; GO:0007613; GO:0032991; GO:0035176; GO:0043231; GO:0045892; GO:0048286","intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; social behavior [GO:0035176]"
"119","PGEN_.00g134810","nucleic acid binding activity",7.25214358208447e-05,"Scaffold_06",14374044,14397031,"P18887","XRCC1_HUMAN","DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1)","GO:0000012; GO:0000724; GO:0000784; GO:0000790; GO:0001666; GO:0005634; GO:0005654; GO:0005730; GO:0006283; GO:0006284; GO:0006288; GO:0006297; GO:0006303; GO:0010033; GO:0010836; GO:0019899; GO:0021587; GO:0021766; GO:0032356; GO:0033194; GO:0042493; GO:0050882; GO:0061819; GO:0070522; GO:1903518; GO:1904877; GO:1905765; GO:1990414; GO:1990599","ERCC4-ERCC1 complex [GO:0070522]; nuclear chromatin [GO:0000790]; nuclear chromosome, telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; base-excision repair [GO:0006284]; base-excision repair, DNA ligation [GO:0006288]; cerebellum morphogenesis [GO:0021587]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide-excision repair, DNA gap filling [GO:0006297]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to drug [GO:0042493]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; transcription-coupled nucleotide-excision repair [GO:0006283]; voluntary musculoskeletal movement [GO:0050882]"
"120","PGEN_.00g150440","nucleic acid binding activity",0.000589845010677184,"Scaffold_06",55514168,55584707,"Q6ZRS2","SRCAP_HUMAN","Helicase SRCAP (EC 3.6.4.-) (Domino homolog 2) (Snf2-related CBP activator)","GO:0000812; GO:0003677; GO:0003713; GO:0004386; GO:0004402; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0006338; GO:0006357; GO:0016032; GO:0016458; GO:0016604; GO:0016887; GO:0032991; GO:0042393; GO:0043044; GO:0043486; GO:0048471","Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; histone exchange [GO:0043486]; regulation of transcription by RNA polymerase II [GO:0006357]; viral process [GO:0016032]"
"121","PGEN_.00g153440","nucleic acid binding activity",0.000949118595781945,"Scaffold_07",1957825,2067352,"O77245","E75_METEN","Nuclear hormone receptor E75 (Nuclear receptor subfamily 1 group D member 3)","GO:0003700; GO:0003707; GO:0005634; GO:0008270; GO:0043565","nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]"
"122","PGEN_.00g166390","nucleic acid binding activity",0.0449923819852984,"Scaffold_07",37456333,37521639,"Q5R9H4","A1CF_PONAB","APOBEC1 complementation factor (APOBEC1-stimulating protein)","GO:0003727; GO:0005737; GO:0005783; GO:0006397; GO:0016556; GO:0030895; GO:0050821","apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; single-stranded RNA binding [GO:0003727]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; protein stabilization [GO:0050821]"
"123","PGEN_.00g167700","nucleic acid binding activity",0.000206909520641,"Scaffold_07",40985364,41016975,"P98169","ZXDB_HUMAN","Zinc finger X-linked protein ZXDB","GO:0003676; GO:0005634; GO:0046872","nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]"
"124","PGEN_.00g174670","nucleic acid binding activity",0.00510873132989795,"Scaffold_08",17971462,17990059,"Q8AVJ2","L14AB_XENLA","Protein LSM14 homolog A-B (RNA-associated protein 55A-B) (RAP55A-B)","GO:0000932; GO:0003723; GO:0005737; GO:0007275; GO:0010494; GO:0017148; GO:0017151; GO:1990904","cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904]; DEAD/H-box RNA helicase binding [GO:0017151]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275]; negative regulation of translation [GO:0017148]"
"125","PGEN_.00g183880","nucleic acid binding activity",2.13972397797621e-11,"Scaffold_08",41644440,41659729,"P21894","SYAC_BOMMO","Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)","GO:0000049; GO:0004813; GO:0005524; GO:0005737; GO:0006419; GO:0008270","cytoplasm [GO:0005737]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]"
"126","PGEN_.00g186340","nucleic acid binding activity",0.0458153347026951,"Scaffold_08",48023289,48087407,"Q69ZB8","ZCHC2_MOUSE","Zinc finger CCHC domain-containing protein 2","GO:0003676; GO:0005737; GO:0008270; GO:0035091","cytoplasm [GO:0005737]; nucleic acid binding [GO:0003676]; phosphatidylinositol binding [GO:0035091]; zinc ion binding [GO:0008270]"
"127","PGEN_.00g203340","nucleic acid binding activity",0.0170947804693506,"Scaffold_09",36039731,36080013,"Q32L09","SHFL_BOVIN","Shiftless antiviral inhibitor of ribosomal frameshifting protein homolog (SHFL) (Repressor of yield of DENV protein homolog) (RyDEN)","GO:0000932; GO:0003723; GO:0005634; GO:0005737; GO:0006449; GO:0034340; GO:0034341; GO:0034342; GO:0043022; GO:0045071; GO:0051607; GO:0075523; GO:1990825; GO:2001125","cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; defense response to virus [GO:0051607]; negative regulation of translational frameshifting [GO:2001125]; negative regulation of viral genome replication [GO:0045071]; regulation of translational termination [GO:0006449]; response to interferon-gamma [GO:0034341]; response to type I interferon [GO:0034340]; response to type III interferon [GO:0034342]; viral translational frameshifting [GO:0075523]"
"128","PGEN_.00g204470","nucleic acid binding activity",4.26510178276057e-10,"Scaffold_10",450153,503366,"P41221","WNT5A_HUMAN","Protein Wnt-5a","GO:0000187; GO:0001736; GO:0001756; GO:0001837; GO:0001938; GO:0001947; GO:0002053; GO:0002088; GO:0002741; GO:0003323; GO:0003402; GO:0003408; GO:0003700; GO:0005109; GO:0005115; GO:0005125; GO:0005543; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0007223; GO:0007257; GO:0007411; GO:0007442; GO:0007494; GO:0008584; GO:0008595; GO:0009986; GO:0010033; GO:0010595; GO:0010628; GO:0010800; GO:0010820; GO:0010976; GO:0016055; GO:0019904; GO:0021891; GO:0030182; GO:0030216; GO:0030324; GO:0030514; GO:0030665; GO:0030666; GO:0030669; GO:0031012; GO:0032092; GO:0032148; GO:0032729; GO:0032755; GO:0033138; GO:0034613; GO:0035567; GO:0036342; GO:0036517; GO:0036518; GO:0038031; GO:0040037; GO:0042060; GO:0042733; GO:0043032; GO:0043066; GO:0043122; GO:0044212; GO:0045080; GO:0045165; GO:0045198; GO:0045599; GO:0045732; GO:0045745; GO:0045766; GO:0045778; GO:0045807; GO:0045836; GO:0045892; GO:0045893; GO:0045944; GO:0048018; GO:0048022; GO:0048146; GO:0048341; GO:0048570; GO:0048706; GO:0048806; GO:0048843; GO:0048850; GO:0050680; GO:0050718; GO:0050727; GO:0050729; GO:0050807; GO:0051092; GO:0051216; GO:0051885; GO:0051964; GO:0060028; GO:0060029; GO:0060065; GO:0060067; GO:0060068; GO:0060070; GO:0060071; GO:0060157; GO:0060324; GO:0060340; GO:0060599; GO:0060638; GO:0060686; GO:0060744; GO:0060750; GO:0060760; GO:0060762; GO:0060775; GO:0060809; GO:0060907; GO:0061024; GO:0061036; GO:0061347; GO:0061348; GO:0061349; GO:0061350; GO:0061354; GO:0062009; GO:0070062; GO:0070245; GO:0071222; GO:0071277; GO:0071300; GO:0071346; GO:0071425; GO:0071560; GO:0072201; GO:0090009; GO:0090037; GO:0090090; GO:0090103; GO:0090179; GO:0090630; GO:0097325; GO:0098794; GO:0098978; GO:0099054; GO:0099068; GO:0099175; GO:0099566; GO:0150012; GO:1900020; GO:1901216; GO:1902379; GO:1902474; GO:1903827; GO:1904469; GO:1904861; GO:1904862; GO:1904934; GO:1904938; GO:1904953; GO:1904955; GO:2000049; GO:2000052; GO:2000484","cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated vesicle membrane [GO:0030665]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; DNA-binding transcription factor activity [GO:0003700]; frizzled binding [GO:0005109]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase-like orphan receptor binding [GO:0005115]; transcription regulatory region DNA binding [GO:0044212]; activation of GTPase activity [GO:0090630]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; activation of protein kinase B activity [GO:0032148]; anterior/posterior axis specification, embryo [GO:0008595]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular protein localization [GO:0034613]; cellular response to calcium ion [GO:0071277]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cervix development [GO:0060067]; chemoattraction of serotonergic neuron axon [GO:0036517]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in organogenesis [GO:0060029]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; epithelial to mesenchymal transition [GO:0001837]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; excitatory synapse assembly [GO:1904861]; face development [GO:0060324]; genitalia development [GO:0048806]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; hindgut morphogenesis [GO:0007442]; hypophysis morphogenesis [GO:0048850]; inhibitory synapse assembly [GO:1904862]; keratinocyte differentiation [GO:0030216]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; male gonad development [GO:0008584]; mammary gland branching involved in thelarche [GO:0060744]; melanocyte proliferation [GO:0097325]; membrane organization [GO:0061024]; mesenchymal-epithelial cell signaling [GO:0060638]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; midgut development [GO:0007494]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in midbrain [GO:1904934]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of melanin biosynthetic process [GO:0048022]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of synapse assembly [GO:0051964]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; notochord morphogenesis [GO:0048570]; olfactory bulb interneuron development [GO:0021891]; optic cup formation involved in camera-type eye development [GO:0003408]; paraxial mesoderm formation [GO:0048341]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in axon guidance [GO:1904938]; planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:0061350]; planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:0061349]; planar cell polarity pathway involved in gastrula mediolateral intercalation [GO:0060775]; planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation [GO:1904955]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar cell polarity pathway involved in outflow tract morphogenesis [GO:0061347]; planar cell polarity pathway involved in pericardium morphogenesis [GO:0061354]; planar cell polarity pathway involved in ventricular septum morphogenesis [GO:0061348]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of chemokine biosynthetic process [GO:0045080]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta secretion [GO:0050718]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 secretion [GO:2000484]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of timing of anagen [GO:0051885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; post-anal tail morphogenesis [GO:0036342]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; primitive streak formation [GO:0090009]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of cellular protein localization [GO:1903827]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of postsynapse organization [GO:0099175]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of synapse organization [GO:0050807]; response to organic substance [GO:0010033]; secondary palate development [GO:0062009]; somitogenesis [GO:0001756]; type B pancreatic cell development [GO:0003323]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]"
"129","PGEN_.00g207680","nucleic acid binding activity",0.0173558004247162,"Scaffold_10",9555364,9586773,"Q6P8G1","ILF2_XENTR","Interleukin enhancer-binding factor 2 homolog","GO:0003677; GO:0003725; GO:0005524; GO:0005634; GO:0005730; GO:0006351; GO:0006955; GO:0016740; GO:0045893","nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; transferase activity [GO:0016740]; immune response [GO:0006955]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]"
"130","PGEN_.00g220380","nucleic acid binding activity",6.42259222899004e-10,"Scaffold_10",42739240,42908587,"Q9UHD2","TBK1_HUMAN","Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1)","GO:0003676; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007249; GO:0009615; GO:0010008; GO:0010629; GO:0016032; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0032479; GO:0032480; GO:0032481; GO:0032606; GO:0032727; GO:0032728; GO:0033138; GO:0035666; GO:0042802; GO:0043123; GO:0043231; GO:0044565; GO:0045087; GO:0045359; GO:0045944; GO:0050830; GO:0051219; GO:0051607; GO:0060340; GO:0071345; GO:1901214; GO:1904417","cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; cellular response to cytokine stimulus [GO:0071345]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type I interferon production [GO:0032480]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta biosynthetic process [GO:0045359]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of neuron death [GO:1901214]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; type I interferon production [GO:0032606]; viral process [GO:0016032]"
"131","PGEN_.00g233580","nucleic acid binding activity",0.0404096067229422,"Scaffold_11",27099534,27108460,"P68372","TBB4B_MOUSE","Tubulin beta-4B chain (Tubulin beta-2C chain)","GO:0000226; GO:0000278; GO:0003725; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0043209; GO:0045298","cytoplasm [GO:0005737]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; tubulin complex [GO:0045298]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]"
"132","PGEN_.00g242340","nucleic acid binding activity",0.00439561497746984,"Scaffold_11",51359268,51378202,"Q01705","NOTC1_MOUSE","Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]","GO:0000122; GO:0000139; GO:0000978; GO:0001228; GO:0001669; GO:0001701; GO:0001708; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002051; GO:0002052; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003256; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003700; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005887; GO:0005912; GO:0006357; GO:0006959; GO:0007050; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009986; GO:0010001; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0019899; GO:0021515; GO:0021915; GO:0030027; GO:0030154; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0043065; GO:0043086; GO:0043235; GO:0043565; GO:0045070; GO:0045165; GO:0045596; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0045967; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050434; GO:0050678; GO:0050679; GO:0050767; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060411; GO:0060412; GO:0060528; GO:0060548; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061314; GO:0061344; GO:0061384; GO:0061419; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071372; GO:0071944; GO:0072017; GO:0072044; GO:0072144; GO:0072602; GO:0090051; GO:0090090; GO:0097150; GO:0120163; GO:1901189; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000737; GO:2000811; GO:2000974; GO:2001027","acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermis development [GO:0008544]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell death [GO:0060548]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; osteoblast fate commitment [GO:0002051]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral transcription [GO:0050434]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]"
"133","PGEN_.00g245920","nucleic acid binding activity",0.000112044076940847,"Scaffold_12",9268299,9326841,"Q99973","TEP1_HUMAN","Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog)","GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904","chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722]"
"134","PGEN_.00g253780","nucleic acid binding activity",0.0112980860044613,"Scaffold_12",33866129,33892979,"Q8N7Q3","ZN676_HUMAN","Zinc finger protein 676","GO:0003677; GO:0005634; GO:0006355; GO:0046872","nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
"135","PGEN_.00g256280","nucleic acid binding activity",0.00438032260364062,"Scaffold_12",41267609,41297324,"O95786","DDX58_HUMAN","Antiviral innate immune response receptor RIG-I (DEAD box protein 58) (Probable ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (RIG-I-like receptor 1) (RLR-1) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I)","GO:0002230; GO:0002735; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010628; GO:0015629; GO:0016032; GO:0016579; GO:0030334; GO:0031625; GO:0032480; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0034344; GO:0035549; GO:0039528; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051091; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1902741; GO:1904469; GO:1990904; GO:2000778","actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; negative regulation of type I interferon production [GO:0032480]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein deubiquitination [GO:0016579]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]; viral process [GO:0016032]"
"136","PGEN_.00g263030","nucleic acid binding activity",0.000583032660031357,"Scaffold_13",9199321,9232997,"O57683","SF3B1_XENLA","Splicing factor 3B subunit 1 (146 kDa nuclear protein) (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)","GO:0000245; GO:0003729; GO:0005634; GO:0005681","nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; spliceosomal complex assembly [GO:0000245]"
"137","PGEN_.00g279490","nucleic acid binding activity",0.00400231353163242,"Scaffold_14",7958021,8006440,"P42231","STA5A_SHEEP","Signal transducer and activator of transcription 5A (Mammary gland factor)","GO:0001553; GO:0001779; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0007259; GO:0007565; GO:0007595; GO:0008284; GO:0019218; GO:0019221; GO:0019915; GO:0030155; GO:0030856; GO:0030879; GO:0040018; GO:0042104; GO:0043029; GO:0043066; GO:0045086; GO:0045579; GO:0045647; GO:0045931; GO:0045944; GO:0046543; GO:0050729; GO:0060397","cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; cytokine-mediated signaling pathway [GO:0019221]; development of secondary female sexual characteristics [GO:0046543]; female pregnancy [GO:0007565]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mammary gland development [GO:0030879]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; regulation of steroid metabolic process [GO:0019218]; T cell homeostasis [GO:0043029]"
"138","PGEN_.00g281640","nucleic acid binding activity",0.0142443221794112,"Scaffold_14",13210361,13237095,"Q02395","MTF2_MOUSE","Metal-response element-binding transcription factor 2 (Metal regulatory transcription factor 2) (Metal-response element DNA-binding protein M96) (Polycomb-like protein 2) (mPCl2) (Zinc-regulated factor 1) (ZiRF1)","GO:0000122; GO:0000977; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005925; GO:0006325; GO:0007379; GO:0019827; GO:0035064; GO:0043565; GO:0045893; GO:0045944; GO:0046872; GO:0048863; GO:0061086; GO:0061087; GO:1990830","cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; segment specification [GO:0007379]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]"
"139","PGEN_.00g284780","nucleic acid binding activity",2.37027667780287e-05,"Scaffold_14",21103586,21136085,"P45448","NR5A2_MOUSE","Nuclear receptor subfamily 5 group A member 2 (Liver receptor homolog 1) (LRH-1)","GO:0000976; GO:0000978; GO:0001228; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0003707; GO:0004879; GO:0005543; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008206; GO:0008270; GO:0009755; GO:0009888; GO:0030855; GO:0031018; GO:0042127; GO:0042632; GO:0043565; GO:0044212; GO:0045070; GO:0045893; GO:0045944; GO:0061113; GO:0090575; GO:0097720; GO:1990830","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; nuclear receptor activity [GO:0004879]; phospholipid binding [GO:0005543]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; bile acid metabolic process [GO:0008206]; calcineurin-mediated signaling [GO:0097720]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol homeostasis [GO:0042632]; endocrine pancreas development [GO:0031018]; epithelial cell differentiation [GO:0030855]; hormone-mediated signaling pathway [GO:0009755]; pancreas morphogenesis [GO:0061113]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]; tissue development [GO:0009888]"
"140","PGEN_.00g296310","nucleic acid binding activity",0.026745652362241,"Scaffold_14",44456985,44458619,"O60290","ZN862_HUMAN","Zinc finger protein 862","GO:0003676; GO:0005634; GO:0006355; GO:0046872; GO:0046983","nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]"
"141","PGEN_.00g304970","nucleic acid binding activity",0.00195596599261518,"Scaffold_15",19841457,19849321,"D2GZW6","VRTN_AILME","Vertnin","GO:0004803; GO:0006313; GO:0043565","sequence-specific DNA binding [GO:0043565]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]"
"142","PGEN_.00g305680","nucleic acid binding activity",0.000352867222794435,"Scaffold_15",21853239,21888214,"O88873","GMEB2_RAT","Glucocorticoid modulatory element-binding protein 2 (GMEB-2)","GO:0000978; GO:0000981; GO:0001228; GO:0003713; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0046872","cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]"
"143","PGEN_.00g305950","nucleic acid binding activity",0.0387237915381078,"Scaffold_15",22414331,22435708,"Q9UJW7","ZN229_HUMAN","Zinc finger protein 229","GO:0003677; GO:0005634; GO:0006355; GO:0046872","nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
"144","PGEN_.00g309470","nucleic acid binding activity",0.00267647394697991,"Scaffold_15",31715425,31764687,"Q9UKV8","AGO2_HUMAN","Protein argonaute-2 (Argonaute2) (hAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (PAZ Piwi domain protein) (PPD) (Protein slicer)","GO:0000340; GO:0000932; GO:0000993; GO:0001047; GO:0003723; GO:0003725; GO:0003727; GO:0003743; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0005845; GO:0006412; GO:0007223; GO:0008022; GO:0009791; GO:0010501; GO:0010586; GO:0010628; GO:0010629; GO:0016020; GO:0016442; GO:0030054; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0035087; GO:0035194; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035280; GO:0042985; GO:0045766; GO:0045944; GO:0045947; GO:0046872; GO:0060213; GO:0060964; GO:0070062; GO:0070551; GO:0070578; GO:0090624; GO:0090625; GO:0098808; GO:1900153; GO:1901165; GO:1905618; GO:1990904","cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of gene expression [GO:0010629]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; posttranscriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; regulation of gene silencing by miRNA [GO:0060964]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; translation [GO:0006412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]"
"145","PGEN_.00g312300","nucleic acid binding activity",0.0251401119320496,"Scaffold_15",39020553,39070876,"Q9BTC0","DIDO1_HUMAN","Death-inducer obliterator 1 (DIO-1) (hDido1) (Death-associated transcription factor 1) (DATF-1)","GO:0003723; GO:0005634; GO:0005737; GO:0005819; GO:0006351; GO:0046872; GO:0097190","cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; apoptotic signaling pathway [GO:0097190]; transcription, DNA-templated [GO:0006351]"
"146","PGEN_.00g316200","nucleic acid binding activity",2.3795924073974e-25,"Scaffold_16",891188,960534,"O00411","RPOM_HUMAN","DNA-directed RNA polymerase, mitochondrial (MtRPOL) (EC 2.7.7.6)","GO:0001018; GO:0003723; GO:0003899; GO:0005739; GO:0005759; GO:0006390; GO:0006391; GO:0007005; GO:0032991; GO:0034245; GO:0042645; GO:0043565","mitochondrial DNA-directed RNA polymerase complex [GO:0034245]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; mitochondrial transcription [GO:0006390]; mitochondrion organization [GO:0007005]; transcription initiation from mitochondrial promoter [GO:0006391]"
"147","PGEN_.00g326070","nucleic acid binding activity",1.186028606726e-06,"Scaffold_16",28622353,28656089,"Q5U249","ELYS_XENLA","Protein ELYS (Protein MEL-28) (xELYS)","GO:0003677; GO:0005643; GO:0005654; GO:0005737; GO:0015031; GO:0051028","cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; mRNA transport [GO:0051028]; protein transport [GO:0015031]"
"148","PGEN_.00g329240","nucleic acid binding activity",0.0134989624783679,"Scaffold_17",6007570,6010893,"Q9UII5","ZN107_HUMAN","Zinc finger protein 107 (Zinc finger protein 588) (Zinc finger protein ZFD25)","GO:0003677; GO:0005634; GO:0046872","nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]"
"149","PGEN_.00g330150","nucleic acid binding activity",2.76271667193264e-07,"Scaffold_17",8401718,8474909,"Q14590","ZN235_HUMAN","Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6)","GO:0003677; GO:0005634; GO:0006355; GO:0046872","nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
"150","PGEN_.00g336990","nucleic acid binding activity",0.00500041961166383,"Scaffold_17",29255941,29260714,"Q9UPN9","TRI33_HUMAN","E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)","GO:0000122; GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0008270; GO:0016567; GO:0017015; GO:0030514; GO:0045892; GO:0070410; GO:0070412","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]"
"151","PGEN_.00g338720","nucleic acid binding activity",0.0477793160025518,"Scaffold_17",33504439,33537774,"P10076","ZFP26_MOUSE","Zinc finger protein 26 (Zfp-26) (Protein mKR3)","GO:0003677; GO:0005634; GO:0006355; GO:0046872","nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]"
"152","PGEN_.00g343770","nucleic acid binding activity",0.0339173855312945,"Scaffold_18",12077288,12079383,"O15164","TIF1A_HUMAN","Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)","GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005102; GO:0005634; GO:0005654; GO:0005719; GO:0005726; GO:0005829; GO:0006366; GO:0008270; GO:0008285; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0045893; GO:0046777; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796","cytosol [GO:0005829]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]"
"153","PGEN_.00g347890","nucleic acid binding activity",0.000628941993951094,"Scaffold_18",23285051,23301363,"Q2KHR2","RFX7_HUMAN","DNA-binding protein RFX7 (Regulatory factor X 7) (Regulatory factor X domain-containing protein 2)","GO:0000790; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357","nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]"
"154","PGEN_.00g348700","nucleic acid binding activity",0.00175823159181687,"Scaffold_18",25609412,25615788,"Q9UPN9","TRI33_HUMAN","E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)","GO:0000122; GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0008270; GO:0016567; GO:0017015; GO:0030514; GO:0045892; GO:0070410; GO:0070412","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]"
"155","PGEN_.00g035120","translational apparatus",0.0203622038568379,"Scaffold_02",5464063,5477585,"P12001","RL18_RAT","60S ribosomal protein L18","GO:0002181; GO:0003735; GO:0005791; GO:0022625; GO:0042788; GO:0045202; GO:0097421","cytosolic large ribosomal subunit [GO:0022625]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; liver regeneration [GO:0097421]"
